HomeLGND • NASDAQ
Ligand Pharmaceuticals Inc
$106.05
1.79%
+1.87 Today
Jun 6, 3:40:13 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
-50M050M
Revenue
Net Income
Revenue
Net income
(USD)Mar 2025Y/Y change
Revenue
45.33M46.34%
Operating expense
27.06M41.39%
Net income
-42.45M-149.28%
Net profit margin
-93.64-133.68%
Earnings per share
1.3310.83%
EBITDA
-28.35M-341.22%
Effective tax rate
15.40%
0500M
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD)Mar 2025Y/Y change
Cash and short-term investments
208.90M-32.74%
Total assets
905.44M-0.92%
Total liabilities
109.90M2.38%
Total equity
795.53M
Shares outstanding
19.29M
Price to book
2.52
Return on assets
-9.92%
Return on capital
-11.19%
-20M020M40M
Net Change in Cash
Net change in cash
(USD)Mar 2025Y/Y change
Net income
-42.45M-149.28%
Cash from operations
-25.45M-235.84%
Cash from investing
4.89M229.64%
Cash from financing
-4.75M-138.97%
Net change in cash
-24.32M-189.61%
Free cash flow
-9.86M-135.75%
StockUS listed security
Previous close
$104.18
Day range
$103.68 - $106.70
Year range
$77.44 - $129.90
Market cap
2.05B USD
Avg Volume
109.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company located in Jupiter, Florida. Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further. The company has been the subject of multiple regulatory investigations, negative shorts-seller reports and class action lawsuits amid allegations of securities fraud. In 2018 its CEO was listed among the top five highest paid CEOs in San Diego. Wikipedia
Founded
Sep 1987
Website
Employees
68
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Main menu
Google apps